Metabolic profiling of tyrosine kinase inhibitor nintedanib using metabolomics

Zimeng Zhou(Jiangxi University of Traditional Chinese Medicine), Fei Li(Henan Agricultural University), Yan Cheng(Fujian Agriculture and Forestry University), Kang Xu(Carnegie Mellon University), Ting Zhang(Central South University), Xue‐Rong Xiao(University of Tübingen), Yikun Wang(Kunming Institute of Botany), Jian-He Fang(Jiangxi University of Traditional Chinese Medicine)
Journal of Pharmaceutical and Biomedical Analysis
December 16, 2019
10.1016/j.jpba.2019.113045
Cited by 11

Related Papers

Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms
|Gut|2020|1.4k
Lithium Metal Batteries Enabled by Synergetic Additives in Commercial Carbonate Electrolytes
|ACS Energy Letters|2021|342
Mobile Ions in Composite Solids
|Chemical Reviews|2020|334
Structural origin of the high-voltage instability of lithium cobalt oxide
|Nature Nanotechnology|2021|334
Aqueous lithium‐ion batteries
|Carbon Energy|2021|213